This is an investigational study. Paclitaxel and carboplatin are FDA approved and commercially available for the treatment of breast cancer. Panitumumab is FDA approved and commercially available for the treatment of colorectal cancer. It is currently being used for research purposes only in the breast cancer setting. The study doctor can explain how the study drugs are designed to work.